KYMR
Kymera Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KYMR fundamentals
Kymera Therapeutics (KYMR) released its earnings on Nov 4, 2025: revenue was 2.76M (YoY -26.20%), missed estimates; EPS was -0.94 (YoY -14.63%), missed estimates.
Revenue / YoY
2.76M
-26.20%
EPS / YoY
-0.94
-14.63%
Report date
Nov 4, 2025
KYMR Earnings Call Summary for Q3,2025
- KT-621 Milestone Progress: Phase Ib AD trial fully enrolled; Phase IIb AD and asthma trials initiated.
- Financial Strength: $978M cash runway, with $2.8M Q3 revenue from Gilead.
- Pipeline Expansion: IRF5 program advancing to clinic; oncology partnership with Gilead for CDK2 program.
- Efficacy Expectations: KT-621 targeting dupilumab-like TARC reduction (70-80%) in AD, with Phase Ib data due in December.
EPS
Revenue
Revenue & Expenses
KYMR has released its 2025 Q3 earnings report, with revenue of 2.76M, reflecting a YoY change of -26.12%, and net profit of -82.17M, showing a YoY change of -31.51%. The Sankey diagram below clearly presents KYMR's revenue sources and cost distribution.
Key Indicators
Kymera Therapeutics (KYMR) key financial stats and ratios, covering profitability, financial health, and leverage.
Kymera Therapeutics (KYMR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Kymera Therapeutics (KYMR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Kymera Therapeutics (KYMR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Kymera Therapeutics (KYMR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Kymera Therapeutics (KYMR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Kymera Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Kymera Therapeutics year over year?What is Kymera Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Kymera Therapeutics’s earnings call?What is Kymera Therapeutics's gross profit margin?What is the market's earnings forecast for Kymera Therapeutics next quarter?What guidance did Kymera Therapeutics's management provide for the next earnings period?Did Kymera Therapeutics beat or miss consensus estimates last quarter?
